OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAD(P)H: quinone oxidoreductase 1 attenuates oxidative stress and apoptosis by regulating Sirt1 in diabetic nephropathy
Duojun Qiu, Shan Song, Yuhan Wang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
Qi Jin, Tong‐Tong Liu, Yuan Qiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 122

Pharmacological potential of Astragali Radix for the treatment of kidney diseases
Yue Shi, Xiujie Shi, Mingming Zhao, et al.
Phytomedicine (2023) Vol. 123, pp. 155196-155196
Closed Access | Times Cited: 27

Redox-regulating nanotherapeutics potentiating ferroptosis-driven cancer treatment
Xiaohong Yang, Xinxin Sun, Jin Lei, et al.
Chemical Engineering Journal (2024) Vol. 484, pp. 149518-149518
Closed Access | Times Cited: 10

Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling.
Yaoxia Zhang, Yuanyuan Qu, Ruiping Cai, et al.
European Journal of Pharmacology (2024) Vol. 976, pp. 176699-176699
Closed Access | Times Cited: 9

Nutraceutical activation of Sirt1: a review
James J. DiNicolantonio, Mark F. McCarty, James H. O’Keefe
Open Heart (2022) Vol. 9, Iss. 2, pp. e002171-e002171
Open Access | Times Cited: 34

Modulation of atherosclerosis‐related signaling pathways by Chinese herbal extracts: Recent evidence and perspectives
Changxing Liu, Xinyi Guo, Xulong Zhang
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2892-2930
Closed Access | Times Cited: 5

Reductive stress: The key pathway in metabolic disorders induced by overnutrition
Shiyi Zhang, Na Wang, Zhichao Gao, et al.
Journal of Advanced Research (2025)
Open Access

Prrx1 promotes mesangial cell proliferation and kidney fibrosis through YAP in diabetic nephropathy
Xu Liu, Jiasen Shi, Huan Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101247-101247
Open Access

Role of sirtuins in metabolic disease-related renal injury
Huanhuan Chen, Yixiao Zhang, Jia-Le Lv, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114417-114417
Open Access | Times Cited: 12

Maresin1 alleviates liver ischemia/reperfusion injury by reducing liver macrophage pyroptosis
Tong Li, Houshuai Zeng, Wenjing Xian, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12

Menaquinone-4 prevents medication-related osteonecrosis of the jaw through the SIRT1 signaling-mediated inhibition of cellular metabolic stresses-induced osteoblast apoptosis
Yajun Cui, Weidong Zhang, Panpan Yang, et al.
Free Radical Biology and Medicine (2023) Vol. 206, pp. 33-49
Closed Access | Times Cited: 11

Transcriptome-wide N6-methyladenosinem modifications analysis of growth and fumonisins production in Fusarium proliferatum causing banana crown rot
Lihong Xie, Linyan Feng, Yan-Ling Ren, et al.
International Journal of Biological Macromolecules (2025), pp. 140385-140385
Closed Access

Lipid metabolism disorders contribute to hepatotoxicity of ICR mice induced by nitrosamines exposure
Hu Zhang, Lu Lu, Chao Zhao, et al.
Environment International (2022) Vol. 167, pp. 107423-107423
Open Access | Times Cited: 16

Vitamin E/Coenzyme Q-Dependent “Free Radical Reductases”: Redox Regulators in Ferroptosis
Valerian E. Kagan, Adam C. Straub, Yulia Y. Tyurina, et al.
Antioxidants and Redox Signaling (2023) Vol. 40, Iss. 4-6, pp. 317-328
Closed Access | Times Cited: 9

NRF2: A crucial regulator for mitochondrial metabolic shift and prostate cancer progression
Brigitta Buttari, Marzia Arese, Rebecca E. Oberley‐Deegan, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 14

SIRT1 as a Potential Therapeutic Target for Chronic Obstructive Pulmonary Disease
Siqi Li, Qiong Huang, Baimei He
Lung (2023) Vol. 201, Iss. 2, pp. 201-215
Closed Access | Times Cited: 8

Tenovin-1 Ameliorates Renal Fibrosis in High-Fat-Diet-Induced Diabetic Nephropathy via Antioxidant and Anti-Inflammatory Pathways
Amit Kundu, Sreevarsha Gali, Swati Sharma, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1812-1812
Open Access | Times Cited: 13

Nrf2 Signaling Pathway as a Key to Treatment for Diabetic Dyslipidemia and Atherosclerosis
Michelle Yi, Arvin John Toribio, Yusuf Muhammad Salem, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5831-5831
Open Access | Times Cited: 2

Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy
Qirui Li, Huiying Xu, Rui-Ting Ma, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 10, pp. 2153-2182
Open Access | Times Cited: 2

Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice
Peipei Wang, Ruixue Guo, Xiwen Bai, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 12

Aristolochic acid I aggravates oxidative stress-mediated apoptosis by inhibiting APE1/Nrf2/HO-1 signaling
Qi Zhang, Lei Tian, Yongkang Hu, et al.
Toxicology Mechanisms and Methods (2023) Vol. 34, Iss. 1, pp. 20-31
Closed Access | Times Cited: 5

YuNü-Jian attenuates diabetes-induced cardiomyopathy: integrating network pharmacology and experimental validation
Wei Wang, Ruixia Liu, Yingying Zhu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4

Association of a single nucleotide polymorphism in SOD2 with susceptibility for the development of diabetic nephropathy in patients with type 2 diabetes: A Saudi population study
Samar Sultan, Meshari Al‐Harbi, Nuha Alrayes, et al.
Endocrinology Diabetes & Metabolism (2023) Vol. 6, Iss. 6
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top